Agenus director reports 4,480 and 1,000 shares
Director Marco Tullio Marcucci reports initial direct and spousal holdings of Agenus common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AGENUS INC (AGEN) reported the initial equity holdings of director Marco Tullio Marcucci. As of August 5, 2026, he is reported as beneficial owner of 4,480 shares of common stock held directly and an additional 1,000 shares held indirectly through his spouse. The filing also notes an Exhibit 24 Power of Attorney authorization.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Key Figures
Key Terms
Form 3 regulatory
indirect financial
Power of Attorney regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filed for AGENUS INC (AGEN) disclose?
Does the AGEN Form 3 show any insider buy or sell transactions?
What additional document is referenced in this AGEN Form 3?
AI-generated analysis. How Rhea-AI works. Not financial advice.